Search Within

Isabelle C Riviere

  1. "Immunology Program Faculty"
  2. "Sloan Kettering Institute Faculty"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (13)
Groups
  1. Department of Medicine (30)
  2. GSK Faculty (30)
  3. Hematologic Malignancies, Division of (30)
  4. Immunology Program Faculty (30)
  5. Sloan Kettering Institute Faculty (30)
  6. Center for Hematologic Malignancies (28)

More Groups

People
  1. Michel Sadelain (26)
  2. Richard O'Reilly (17)
  3. Renier Brentjens (14)
  4. Kevin Curran (10)
  5. Nancy Kernan (10)
  6. Jae Park (8)

More People

Years
  1. 2022 (2)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (4)
  5. 2018 (1)
  6. 2017 (1)

More Years

Publications
  1. Blood (11)
  2. Biology of Blood and Marrow Transplantation (4)
  3. Clinical Cancer Research (2)
  4. Nature Biotechnology (2)
  5. Nature Medicine (2)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Hematology (11)
  2. Nature Publishing Group (7)
  3. Elsevier Inc. (5)
  4. American Association for Cancer Research (3)
  5. British Society for Immunology (1)
  6. Solariz, Inc. (1)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Journal Article

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K. V.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • HLA-independent T cell receptors for targeting tumors with low antigen density
    Journal Article

    Mansilla-Soto, J.; Eyquem, J.; Haubner, S.; Hamieh, M.; Feucht, J.; Paillon, N.; Zucchetti, A. E.; Li, Z.; Sjöstrand, M.; Lindenbergh, P. L.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies
    Meeting Abstract

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CD19-specific CAR (19-28Z) T cells predicts response and survival in pediatric relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K.; Margossian, S.; Kernan, N.; Prockop, S.; Boulad, F.; Cancio, M.; Szenes, V.; Kung, A.; Boelens, J. J.; O'Reilly, R.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
    Journal Article

    Hamieh, M.; Dobrin, A.; Cabriolu, A.; van der Stegen, S. J. C.; Giavridis, T.; Mansilla-Soto, J.; Eyquem, J.; Zhao, Z.; Whitlock, B. M.; Miele, M. M.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Intestinal microbiota composition prior to CAR T cell infusion correlates with efficacy and toxicity
    Meeting Abstract

    Smith, M.; Littmann, E. R.; Slingerland, J. B.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Schluter, J.; Park, J. H.; O'Cearbhaill, R.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save